Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Resonance Specialties Ltd
Your Vote -
Buy
50.00%
Hold
25.00%
Sell
25.00%
50.00%
4 users have voted
Option Chain
Analyzes market sentiment, predicts Resonance Specialties Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Resonance Spec. - Announcement under Regulation 30 (LODR)-Dividend Updates
-
Resonance Spec. - Integrated Filing (Financial)
-
Resonance Spec. Q4 net profit zooms 356.72% at Rs 3.06 cr
-
Resonance Spec. - Audited Financial Results For Financial Year Ended 31.03.2025
-
Resonance Spec. - Board Meeting Outcome for Audited Financial Results For The 4Th Quarter And Financial Year Ended March 31,
-
Resonance Spec. - Board Meeting Intimation for To Consider And Approve The Audited Financial Results For The 4Th Quarter And
-
Resonance Spec. has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Resonance Spec. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Key fundamentals
Evaluate the intrinsic value of Resonance Specialties Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 67.1102 | 61.6119 | 57.9116 | 51.8033 | 41.2817 |
| Liabilities | 67.1102 | 61.6119 | 57.9116 | 51.8033 | 41.2817 |
| Equity | 11.544 | 11.544 | 11.544 | 11.544 | 11.544 |
| Gross Profit | 10.5949 | 4.8726 | 6.8223 | 15.2094 | 14.2548 |
| Net Profit | 6.5662 | 2.9684 | 5.0013 | 12.3598 | 10.5241 |
| Cash From Operating Activities | -2.506 | 4.1637 | -8.3708 | 13.3258 | 4.2808 |
| NPM(%) | 8.43 | 5.36 | 8.5 | 16.65 | 14.97 |
| Revenue | 77.8066 | 55.3009 | 58.8146 | 74.2166 | 70.2877 |
| Expenses | 67.2117 | 50.4283 | 51.9923 | 59.0072 | 56.0329 |
| ROE(%) | 10.87 | 4.91 | 8.28 | 20.46 | 17.42 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Resonance Specialties Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Nitta Gelatin India Ltd | 769.00 | 1.54 | 8.32 | 101.38 | 924.57 | 1.04 |
| Sharda Cropchem Ltd | 632.00 | 2.55 | 18.71 | 1007.40 | 337.37 | 1.43 |
| Ram Minerals and Chemicals Ltd | 0.49 | 0.00 | 49.00 | 2297.85 | -0.09 | 0.00 |
| Amines and Plasticizers Ltd | 221.00 | 0.39 | 29.53 | 614.35 | 361.94 | 0.23 |
Company Info
Armour Polymers Limited was incorporated on 1st June, 1989 as a Private Limited Company in the State of Maharashtra and the Company became a Public Limited Company with effect from 3rd March, 1990. Armour Chemicals Limited, the Promoter Company was founded by Dr Atma B Gupta, a technocrat with extensive experience in teaching and research, both in India and abroad. The company set up its manufacturing facilities at Ankleshwar in 1984 at an investment of Rs 16 lacs for manufacture of Ampicillin Trihydrate and Amoxycillin Trihydrate. By 1991 the company has achieved a turnover of Rs 47 crores with a post-tax profit of Rs 1.84 crores. Today, Armour Chemicals Ltd. exports about 70% of its production to European countries, USSR and China. Today Amour Chemicals Ltd. is one of the major producers of several sterile bulk drugs in India and is well known for its innovative R & D and short gestation period of up-scaling the technology in various chemical processes. Armour Chemicals Ltd is the flagship company of the Armour Group which has a combined turnover of Rs. 65 crores. Apart from Armour Chemicals Ltd., the group includes 1. Vista Organics (P) Ltd, is one of the major producers of Pyrazinamide, an anti-TB drug in India. It also manufactures INH, another anti-TB drug, Niacin, Niacinamide, Vitamin and feed supplements, Erythromycin, the well known antibiotic and Zinc picolinate for exports. Its factory is located at Mandideep, Madhya Pradesh. 2. Armour Biotech (P) Ltd. has been recently formed to market Formulated pharmaceuticals. It has the distinction of having a wide range of anti-cancer drugs in its spectrum of activity. 3. Armour International is the export arm of the Armour Group and specializes in international marketing. 4. Vista Finance and Leasing (P) Ltd. and Ushma Investment (P) Ltd are new companies promoted for the purpose of carrying out leasing, investment and financing activities. These companies have recently acquired property which they intend leasing to companies within as well as outside the group. Their proposed participation in the equity of Armour Polymers Ltd will mark the beginning of their investment activities. 2012 -Mr. L. R. Daga has been appointed as additional director of the Company.
Armour Polymers Limited was incorporated on 1st June, 1989 as a Private Limited Company in the State of Maharashtra and the Company became a Public Limited Company with effect from 3rd March, 1990. Armour Chemicals Limited, the Promoter Company was founded by Dr Atma B Gupta, a technocrat with extensive experience in teaching and research, both in India and abroad. The company set up its manufacturing facilities at Ankleshwar in 1984 at an investment of Rs 16 lacs for manufacture of Ampicillin Trihydrate and Amoxycillin Trihydrate. By 1991 the company has achieved a turnover of Rs 47 crores with a post-tax profit of Rs 1.84 crores. Today, Armour Chemicals Ltd. exports about 70% of its production to European countries, USSR and China. Today Amour Chemicals Ltd. is one of the major producers of several sterile bulk drugs in India and is well known for its innovative R & D and short gestation period of up-scaling the technology in various chemical processes. Armour Chemicals Ltd is the flagship company of the Armour Group which has a combined turnover of Rs. 65 crores. Apart from Armour Chemicals Ltd., the group includes 1. Vista Organics (P) Ltd, is one of the major producers of Pyrazinamide, an anti-TB drug in India. It also manufactures INH, another anti-TB drug, Niacin, Niacinamide, Vitamin and feed supplements, Erythromycin, the well known antibiotic and Zinc picolinate for exports. Its factory is located at Mandideep, Madhya Pradesh. 2. Armour Biotech (P) Ltd. has been recently formed to market Formulated pharmaceuticals. It has the distinction of having a wide range of anti-cancer drugs in its spectrum of activity. 3. Armour International is the export arm of the Armour Group and specializes in international marketing. 4. Vista Finance and Leasing (P) Ltd. and Ushma Investment (P) Ltd are new companies promoted for the purpose of carrying out leasing, investment and financing activities. These companies have recently acquired property which they intend leasing to companies within as well as outside the group. Their proposed participation in the equity of Armour Polymers Ltd will mark the beginning of their investment activities. 2012 -Mr. L. R. Daga has been appointed as additional director of the Company.
Read More
Parent Organisation
Resonance Specialties Ltd.
Founded
01/06/1989
Managing Director
NSE Symbol
FAQ
The current price of Resonance Specialties Ltd is
The 52-week high for Resonance Specialties Ltd is
The market capitalization of Resonance Specialties Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Resonance Specialties Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Resonance Specialties Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Resonance Specialties Ltd shares.
The CEO of Resonance Specialties Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
